期刊文献+

波氏假阿利什霉复合种对4种抗真菌药物的敏感性研究 被引量:3

In vitro susceptibility test of clinical isolates of Pseudallescheria boydii complex to four anti-fungus agents
下载PDF
导出
摘要 目的:对23株分子鉴定为赛多孢霉复合种的菌株检测其对伏立康唑、泊沙康唑、伊曲康唑和两性霉素 B 的敏感性。方法参照美国临床实验室标准化研究所制定的 M38A2方案,检测临床来源的9株波氏假阿利什霉(Pseudallescheria boydii)、6株 P.ellipsoidea、1株 P.angusta、1株 P.fusoidea 和6株尖端赛多孢(Scedosporium apiospermum)对伏立康唑、泊沙康唑、伊曲康唑和两性霉素 B 的 MIC 值。结果伏立康唑对所有受试菌株的 MIC 值为0.25~1μg/ mL,泊沙康唑为2~4μg/mL。伊曲康唑对 P.ellipsoidea、尖端赛多孢的 MIC 值为2~>16μg/ mL,对波氏假阿利什霉、P.angusta、P.fusoidea 的 MIC 值为2~4μg/ mL。两性霉素 B 对5种菌的 MIC 值均为为4~>16μg/ mL。结论伏立康唑、泊沙康唑、伊曲康唑和两性霉素 B 对波氏假阿利什复合种中不同种的敏感性未见明显差异。该复合种对伏立康唑最敏感,泊沙康唑其次,伊曲康唑变化较大,两性霉素 B 的效果最差。 Objective To determine the in vitro susceptibility of Pseudallescheria boydii complex to voriconazole ( VRC), posaconazole(POS),itraconazole(ITC)and amphotericin B(AMB).Methods The MICs of VRC,POS,ITC and AMB were determined according to M38A2 methods in nine isolates of P.boydii,six isolates of P.ellipsoidea,one isolate of P.angusta,one isolate of P.fusoidea and six isolates of S.apiospermum.Results The MIC range of VRC and POS were 0.251 μg/ mL and 24 μg/ mL.ITC had higher MIC range which was 2〉16 μg/ mL against P.ellipsoidea and S.apiospermum than P.boydii,P.angusta,and P.fusoidea(24μg/ mL).The MIC range of AMB against all the species was 4〉16 μg/ mL.Conclusion VRC,POS,ITC and AMB have the similar susceptibility patterns against various types of Pseudallescheria boydii complex.Since ITC was more sensitive to P.boydii,P.angusta and P.fusoidea than P.ellipsoidea and S.apiospermum in our study,VRC is the most sensitive drug against all the types and than POS and AMB is the worst one among the four drugs.
出处 《中国真菌学杂志》 CSCD 2015年第2期96-99,共4页 Chinese Journal of Mycology
关键词 波氏假阿利什霉复合种 伏立康唑 泊沙康唑 伊曲康唑 两性霉素B Pseudallescheria boydii complex voriconazole posaconazole itraconazole amphotericin B
  • 相关文献

参考文献17

  • 1Malloch D,Salk in IF.A new species of Scedosporium associated with osteom yelitis in humans [ JJ.Myeotaxon, 1984,21 : 247-255.
  • 2Patrick RM, Ellen JB, Michael AP, et al. Manual of clinical mi- crobiology[ M] .8th ed Washington ASM press,2003:1848-1856.
  • 3Pedro I, Emilio PT, Luis P, et al. Disseminated infection and col- onization by Scedosporium prolificaru:a review of 18 cases 1990- 1999[ J].Clin Infect Dis,2001,32(ll) :158-165.
  • 4Gilgado F, Carlo J, Gen~ J, et al.Molecular phylogeny of the Pseu- dallescheria boydii species complex:proposal of two new species [ J ].J Clin Microbiol. 2005.43 (10) :4930-4942.
  • 5王思卜,张杰,余进,陈少杰,万喆,李若瑜.用ITS和TUB序列差异鉴定临床相关波氏假阿利什霉/尖端赛多孢[J].中华检验医学杂志,2011,34(12):1084-1087. 被引量:2
  • 6Kaltseis J, Rainer J, De Hoog GS.Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environ- ments and their distribution in clinical samples [ J 1. Med Mycol, 2009,47(4) :398-405.
  • 7Zouhair R, Rougeron A, Razafimandimby B, Kobi A, et al. Distri- bution of the different species of the Pseudallescheria boydii/Sce- dosporium apiospermum complex in French patients with cystic fi- brosis[J] .Med Mycol,2013,51 (6) :603-613.
  • 8Lackner M, Rezusta A, Villuendas MC, et al. Infection and colo- nisation due to Scedosporium in Northern Spain.An in vitro anti- fungal susceptibility and molecular epidemiology study of 60 iso- lates[ J] .Mycoses,2011,54(3) : 12-21.
  • 9Cuenca-Estrella M, Ruiz-Diez B, Martinez-Suarez JV, et ai. Com- parative in-vitro activity of voriconazole ( UK-109,496 ) and six other antifungal agents against clinical isolates of Seedosporium prolificans and Scedosporium apiospermum[ J] .J Antimierob Che- mother, 1999,43( 1 ) : 149-151.
  • 10Carrillo A J, Guarro J.In vitro activities of four novel triazoles a- gainst Scedosporium spp [ J ]. Antimicrob Agents Chemother, 2001,45(7) :2151-2153.

二级参考文献34

  • 1Makimura K,Murayama SY,& Yamaguchi H.Detection of a wide range of medical important fungi by the PCR[J].J Med Mycol,1994,40(5):358-364.
  • 2Glass N L,and Donaldson GC.Development of primer sets designed for use with the PCR to amplify genes from filamentous ascomycetes[J].Appl Environ Microbiol,1995,61(4):1323-1330.
  • 3White TJ,Bruns TD,Lee SB,et al.Amplification and direct sequencing of fungal ribosomal RNA gene for phylogenetics[M]//Innes MA,Gelfand DH,Sninsky JJ,et al.PCR protocols:a guide to the methods and application.California:Academic Press,1990:315-322.
  • 4Galgiani JN,Bartlett MS,Ghannoum MA,et al.Reference method for broth dilution antifungal susceptibility testing of yeasts:approved standard[M].Wayne:philadelphia,1997:-15.
  • 5Whyte M,Irving H,O'Regan P,et al.Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia[J].Pediatr Infect Dis,2005,24(4):375-377.
  • 6Marco de Lucas E,Sadaba P,Lastra Garcia-Baron P,et al.Cerebral scedosporiosis:an emerging fungal infection in severe neutropenic patients:CT features and CT pathologic correlation[J].Eur Radiol,2006,16(2):496-502.
  • 7Seung-Beom H,Seung-Joo G,Hyeon-Dong S,et al.Polyphasic taxonomy of Aspergillus fumigatus and related species[J].Mycologia,2005,97(6):1316-1329.
  • 8Wiederhold NP,Lewis RE.Antifungal activity against Scedosporium species and novel assays to assess antifungal phar-macodynamics against filamentous fungi[J].Med Mycol,2009,47(4):422-432.
  • 9Lopez L,Gaztelurrutia L,Cuenca-Estrella M,et al.Infection and colonization by Scedosporium prolificans[J].Enferm Infecc Microbiol Clin,2001,19(7):308-313.
  • 10Rodriguez MM,Calvo E,Serena C,et al.Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans[J].Antimicrob Agents Chemother,2009,53(5):2153-2155.

共引文献20

同被引文献16

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部